发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| England | 626 |
| USA | 260 |
| CHINA MAINLAND | 211 |
| Japan | 167 |
| Italy | 94 |
| France | 77 |
| GERMANY (FED REP GER) | 74 |
| Netherlands | 72 |
| Scotland | 70 |
| South Korea | 69 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| CHRISTIE NHS FOUNDATION TRUST | 79 |
| UNIVERSITY OF LONDON | 76 |
| UNIVERSITY OF MANCHESTER | 54 |
| ROYAL MARSDEN NHS FOUNDATION TRUST | 53 |
| UNICANCER | 41 |
| WYTHENSHAWE HOSPITAL NHS FOUNDATION TRU... | 38 |
| NATIONAL CANCER CENTER - JAPAN | 37 |
| UNIVERSITY OF LEICESTER | 34 |
| TONGJI UNIVERSITY | 32 |
| UNIVERSITY HOSPITALS OF LEICESTER NHS T... | 31 |
文章引用情况
1
Heterogeneity-of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment response2
PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of beta-catenin and snail/slug in non-small cell lung carcinoma cells3
Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma4
Clinical analysis by next-generation sequencing for NSCLC patients with &ITMET&IT amplification resistant to osimertinib5
Community-based lung cancer screening with low-dose CT in China: Results of the baseline screening6
Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer7
Genetic and clinicopathologic characteristics of lung adenocarcinoma with tumor spread through air spaces8
High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naive advanced EGFR-mutant lung adenocarcinoma patients9
Impact of cytotoxic chemotherapy on PD-L1 expression in patients with non-small cell lung cancer negative for EGFR mutation and ALK fusion10
Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer